The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma

British Journal of Cancer

Volumn 107, Issue 8, 2012, Pages 1423-1432

  Hatzimichael, E ^a   Lo Nigro, C ^b   Lattanzio, L ^b   Syed, N ^c   Shah, R ^c   Dasoula, A ^a   Janczar, K ^c   Vivenza, D ^b   Monteverde, M ^b   Merlano, M ^b   Papoudou Bai, A ^a   Bai, M ^a   Schmid, P ^d   Stebbing, J ^c   Bower, M ^e   Dyer, M J S ^f   Karran, L E ^f   Elguetakarstegl, C ^g   Farrell, P J ^g   Thompson, A ^h   Briasoulis, E ^a   Crook, T ^h   more..

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

^e CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Epigenetics; Methylation; Non Hodgkin lymphoma; Prolyl hydroxylases

Indexed keywords

COLLAGEN PROLYL HYDROXYLASE 3; COLLAGEN PROLYL HYDROXYLASE 4; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BONE MARROW; BURKITT LYMPHOMA; COLLAGEN PROLYL HYDROXYLASE 3 GENE; COLLAGEN PROLYL HYDROXYLASE 4 GENE; CONTROLLED STUDY; DNA ISOLATION; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOBLASTOID CELL LINE; LYMPHOMA; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; COLLAGEN; CPG ISLANDS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; LYMPHOMA, B-CELL; METHYLATION; PROCOLLAGEN-PROLINE DIOXYGENASE;

EID: 84867405334     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.380     Document Type: Article

References (25)

1. Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, Munivez E, Keene DR, Hogue WR, Pyott S, Byers PH, Krakow D, Cohn DH, Eyre DR, Lee B, Morello R (2010) Generalized connective tissue disease in Crtap-/- mouse. PloS One 5(5): e10560
2. Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B (2008) CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Human Mutation 29(12): 1435-1442 (Pubitemid 352774897)
3. Belaud-Rotureau MA, Marietta V, Vergier B, Mainhaguiet G, Turmo M, Idrissi Y, Ferrer J, Beylot-Barry M, Dubus P, Merlio JP (2008) Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. Virchows Archiv Int J Pathol 452(6): 607-620
4. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39(3): 359-365 (Pubitemid 46328489)
5. Chaganti RS, Nanjangud G, Schmidt H, Teruya-Feldstein J (2000) Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Sem Hematol 37(4): 396-411
6. de Leval L, Hasserjian RP (2009) Diffuse large B-cell lymphomas and burkitt lymphoma. Hem-oncol Clin N Am 23(4): 791-827
7. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 96(4): 558-566
8. Gryder RM, Lamon M, Adams E (1975) Sequence position of 3-hydroxyproline in basement membrane collagen. Isolation of glycyl- 3-hydroxyprolyl-4- hydroxyproline from swine kidney. J Biol Chem 250(7): 2470-2474
9. Guan H, Xie L, Leithauser F, Flossbach L, Moller P, Wirth T, Ushmorov A (2010) KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood 116(9): 1469-1478
10. Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, Gonzalez-Barca E, Mercadal S, Mate JL, Sancho JM, Arenillas L, Serrano S, Escoda L, Martinez S, Valera A, Martinez A, Jares P, Pinyol M, Garcia-Herrera A, Martinez-Trillos A, Gine E, Villamor N, Campo E, Colomo L, Lopez-Guillermo A (2011) Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood 117(18): 4836-4843
11. Jarnum S, Kjellman C, Darabi A, Nilsson I, Edvardsen K, Aman P (2004) LEPREL1, a novel ER and Golgi resident member of the Leprecan family. Biochem Biophys Res Commun 317(2): 342-351 (Pubitemid 38452488)
12. Kaul SC, Sugihara T, Yoshida A, Nomura H, Wadhwa R (2000) Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan. Oncogene 19(32): 3576-3583 (Pubitemid 30608478)
13. Lee S, Syed N, Taylor J, Smith P, Griffin B, Baens M, Bai M, Bourantas K, Stebbing J, Naresh K, Nelson M, Tuthill M, Bower M, Hatzimichael E, Crook T (2010) DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma. Br J Cancer 103(2): 265-274
14. Mordechai S, Gradstein L, Pasanen A, Ofir R, El Amour K, Levy J, Belfair N, Lifshitz T, Joshua S, Narkis G, Elbedour K, Myllyharju J, Birk OS (2011) High myopia caused by a mutation in LEPREL1, encoding prolyl 3- hydroxylase 2. Am J Human Genet 89(3): 438-445
15. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127(2): 291-304 (Pubitemid 44604299)
16. Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, Li H, Gao Z, Wei W, Bose S, Anderton J, Kapatai G, Reynolds G, Ito A, Marafioti T, Woodman CB, Ambinder R, Tao Q (2010) Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. Am J Pathol 177(3): 1480-1490
17. Ong ST, Le Beau MM (1998) Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Sem Oncol 25(4): 447-460 (Pubitemid 28385722)
18. Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, Fornari A, Martinoglio B, Medico E, Zamo A, Facchetti F, Ponzoni M, Geissinger E, Rosenwald A, Muller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G (2010) Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 28(9): 1583-1590
19. Salaverria I, Siebert R (2011) The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J Clin Oncol 29(14): 1835-1843
20. Shah R, Smith P, Purdie C, Quinlan P, Baker L, Aman P, Thompson AM, Crook T (2009) The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer 100(10): 1687-1696
21. Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O'Nions J, Allday M, Hoffmann I, Crawford D, Griffin B, Farrell PJ, Crook T (2006) Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 107(1): 250-256 (Pubitemid 43053549)
22. Tiainen P, Pasanen A, Sormunen R, Myllyharju J (2008) Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV. J Biol Chem 283(28): 19432-19439
23. Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP consortium program study. Leukemia 29: 2103-2113
24. Vranka JA, Sakai LY, Bachinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279(22): 23615-23621 (Pubitemid 38685676)
25. Wassenhove-McCarthy DJ, McCarthy KJ (1999) Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan. J Biol Chem 274(35): 25004-25017